传统与联合局部光动力疗法治疗基底细胞癌:系统综述与荟萃分析
该系统综述与荟萃分析检索MEDLINE、PubMed、Embase和CENTRAL数据库至2017年9月1日,纳入15项随机对照试验(2327例患者,3509个基底细胞癌)。局部光动力疗法(PDT)对低危基底细胞癌有效且美容效果和安全性好,但5年持续清除率低于切除手术,部分方案低于咪喹莫特,与氟尿嘧啶相似;分次PDT和联合方案需进一步研究。
要点
- PDT对低危基底细胞癌有效,5年持续清除率高但低于切除手术(nBCC RR 0.76,95%CI 0.63-0.91)。
- PDT美容效果优于手术和冷冻手术,严重不良反应少于咪喹莫特。
- 分次PDT和联合PDT方案需进一步研究。
核心结论
- PDT是低危基底细胞癌的有效治疗,美容效果和安全性极好。
- 咪喹莫特疗效高于单周期PDT但不良反应更多。
- 切除手术疗效最高。
- 分次和联合PDT方案需进一步研究。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、PubMed、Embase和CENTRAL数据库从建库至2017年9月1日。
- 纳入15项随机对照试验,共2327例患者、3509个基底细胞癌。
主要发现
- PDT 5年持续清除率低于切除手术(nBCC汇总RR 0.76,95%CI 0.63-0.91)。
- 未对部分缓解病灶再治疗时,PDT 5年持续清除率略低于咪喹莫特(sBCC RR 0.81,95%CI 0.70-0.95),与氟尿嘧啶相似(sBCC RR 0.88,95%CI 0.75-1.04)。
- 传统PDT的5年持续清除率低于分次PDT(sBCC RR 0.76,95%CI 0.68-0.84)。
- PDT美容效果优于手术(sBCC RR 1.68,95%CI 1.32-2.14;nBCC RR 1.82,95%CI 1.19-2.80)和冷冻手术(BCC RR 3.73,95%CI 1.96-7.07),与咪喹莫特(sBCC RR 1.01,95%CI 0.85-1.19)和氟尿嘧啶(sBCC RR 1.04,95%CI 0.88-1.24)相似。
- PDT疼痛峰值高于局部治疗但持续时间更短;严重不良反应少于咪喹莫特(sBCC RR 0.05,95%CI 0.00-0.84)和氟尿嘧啶(sBCC RR 0.11,95%CI 0.01-2.04)。
关键数值与推荐
- PDT 5年持续清除率低于切除手术:nBCC RR 0.76(95%CI 0.63-0.91)。
- 未再治疗部分缓解病灶时,PDT 5年持续清除率低于咪喹莫特(sBCC RR 0.81,95%CI 0.70-0.95),与氟尿嘧啶相似(sBCC RR 0.88,95%CI 0.75-1.04)。
- 传统PDT 5年持续清除率低于分次PDT(sBCC RR 0.76,95%CI 0.68-0.84)。
- PDT美容效果优于手术(sBCC RR 1.68,95%CI 1.32-2.14;nBCC RR 1.82,95%CI 1.19-2.80)和冷冻手术(BCC RR 3.73,95%CI 1.96-7.07)。
- PDT严重不良反应少于咪喹莫特(sBCC RR 0.05,95%CI 0.00-0.84)和氟尿嘧啶(sBCC RR 0.11,95%CI 0.01-2.04)。
临床怎么用
- PDT是低危基底细胞癌的有效治疗选择,美容效果和安全性好。
- 咪喹莫特疗效高于单周期PDT但不良反应更多。
- 切除手术疗效最高。
- 分次和联合PDT方案需进一步研究。
局限性
- 联合PDT方案来自小型研究,结果常无统计学意义。
- 分次和联合PDT方案需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Topical photodynamic therapy (PDT) is an established treatment option for low-risk basal cell carcinoma (BCC). OBJECTIVES: To compare efficacy, cosmesis and tolerability of PDT for BCC with alternative treatments. METHODS: MEDLINE, PubMed, Embase and CENTRAL databases were searched from inception until 1 September 2017. Included studies were randomized controlled trials (RCTs) of PDT for nodular (n) and superficial (s) BCC reporting at least one of the following outcomes: clearance at 3 months and sustained at 1 or 5 years; recurrence at ≥ 1 year; cosmesis; adverse events; tolerability. RESULTS: From 2331 search results, 15 RCTs (2327 patients; 3509 BCCs) were included. PDT efficacy (5-year sustained clearance) was high but inferior to excisional surgery [nBCC pooled risk ratio (RR) 0·76; 95% confidence interval (CI) 0·63-0·91], and without re-treatment of partially responding lesions, was modestly inferior to imiquimod (sBCC: RR 0·81; 95% CI 0·70-0·95) and similar to fluorouracil (sBCC: RR 0·88; 95% CI 0·75-1·04). Five-year sustained clearance was inferior with conventional vs. fractionated PDT (sBCC: RR 0·76; 95% CI 0·68-0·84). PDT cosmesis was superior to surgery (sBCC: RR 1·68, 95% CI 1·32-2·14; nBCC: RR 1·82, 95% CI 1·19-2·80) and cryosurgery (BCC: RR 3·73, 95% CI 1·96-7·07), and without re-treatment of partially responding lesions was similar to imiquimod (sBCC: RR 1·01, 95% CI 0·85-1·19) and fluorouracil (sBCC: RR 1·04, 95% CI 0·88-1·24). Peak pain was higher but of shorter duration with PDT than topical treatments. Serious adverse reactions were rarer with PDT than imiquimod (sBCC: RR 0·05, 95% CI 0·00-0·84) and fluorouracil (sBCC: RR 0·11, 95% CI 0·01-2·04). Combination PDT regimens demonstrated reduced recurrence and improved cosmesis; however, results from these small studies were often nonsignificant. CONCLUSIONS: PDT is an effective treatment for low-risk BCC, with excellent cosmesis and safety. Imiquimod has higher efficacy than single-cycle PDT but more adverse effects. Highest efficacy is with excisional surgery. Fractionated and combination PDT options warrant further study.
引用
- Collier NJ, Haylett AK, Wong TH, et al. Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis. Br J Dermatol. 2018. PMID: 29889302. doi:10.1111/bjd.16838
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。